Operating Lease, Right-of-Use Asset of PLUS THERAPEUTICS, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PLUS THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • PLUS THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $20,000, a 81% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $20,000 -$86,000 -81% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $29,000 -$110,000 -79% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $38,000 -$133,000 -78% 31 Mar 2025 10-Q 30 May 2025 2025 Q1
Q4 2024 $73,000 -$129,000 -64% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $106,000 -$126,000 -54% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $139,000 -$103,000 -43% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $171,000 -$99,000 -37% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $202,000 -$46,000 -19% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $232,000 -$43,000 -16% 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 $242,000 -$61,000 -20% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $270,000 -$46,000 -15% 31 Mar 2023 10-Q 20 Apr 2023 2023 Q1
Q4 2022 $248,000 -$93,000 -27% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $275,000 -$284,000 -51% 30 Sep 2022 10-Q 20 Oct 2022 2022 Q3
Q2 2022 $303,000 -$335,000 -53% 30 Jun 2022 10-Q 21 Jul 2022 2022 Q2
Q1 2022 $316,000 -$284,000 -47% 31 Mar 2022 10-Q 21 Apr 2022 2022 Q1
Q4 2021 $341,000 -$295,000 -46% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $559,000 -$112,000 -17% 30 Sep 2021 10-Q 21 Oct 2021 2021 Q3
Q2 2021 $638,000 -$69,000 -9.8% 30 Jun 2021 10-Q 22 Jul 2021 2021 Q2
Q1 2021 $600,000 -$144,000 -19% 31 Mar 2021 10-Q 22 Apr 2021 2021 Q1
Q4 2020 $636,000 -$145,000 -19% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $671,000 -$147,000 -18% 30 Sep 2020 10-Q 22 Oct 2020 2020 Q3
Q2 2020 $707,000 -$198,000 -22% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $744,000 -$379,000 -34% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $781,000 31 Dec 2019 10-K 22 Feb 2021 2020 FY
Q3 2019 $818,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $905,000 30 Jun 2019 10-Q 15 Aug 2019 2019 Q2
Q1 2019 $1,123,000 31 Mar 2019 8-K 10 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.